Get Started with Galaxy

Resources

Resources Search

Galaxy Provider Asset | Patient ID and Galaxy Test Selection Guide
  • Assets

Patient Identification & Test Selection Guide

Learn how to identify the right patients for Galaxy testing and confidently select the appropriate diagnostic test using this provider-focused[…]

View More ->

  • Webinar Replay, Webinars

REPLAY: From Diagnosis to Protocol: Thinking Through Tick-Borne Illness Cases

Babesia is often present but rarely detected. In this clinical webinar, learn why standard diagnostics fall short, how pathogen biology[…]

View More ->

  • Webinar Replay, Webinars

REPLAY: What to do if You Get Bit

Babesia is often present but rarely detected. In this clinical webinar, learn why standard diagnostics fall short, how pathogen biology[…]

View More ->

Press release graphic announcing Bay Area Lyme Ventures investment in Galaxy Diagnostics to support tick-borne disease diagnostic innovation.
  • Press Release

Bay Area Lyme Ventures Invests in Galaxy Diagnostics to Advance Tick-Borne Disease Testing

Partnership Aims to Accelerate Innovation in Diagnostic Tools for Patients with Complex Tick and Vector-Borne Illnesses DURHAM, N.C., June 2nd,[…]

View More ->

  • Assets

Vector-Borne Disease Overview and Diagnostic Landscape

Look past the complexity of vector-borne disease and get the foundational knowledge you need to navigate it. This guide covers[…]

View More ->

Galaxy Diagnostics clinical education blog image for Babesia detection, low-level parasitemia, discordant results, and triple-draw testing.
  • Blog

The Babesia Detection Problem: Why Results Differ in Low-Level Parasitemia

By Jennifer C. Miller, PhD, Vice President of Clinical & Scientific Operations, Galaxy Diagnostics Summary: Babesia is an intraerythrocytic parasite[…]

View More ->

Load More
No more posts to show
No Results Found